Italy Wants €1.2 Billion From Novartis And Roche In Lucentis/Avastin Saga
This article was originally published in The Pink Sheet Daily
Executive Summary
The Italian government has said it will pursue Roche and Novartis for €1.2 billion it says the Swiss companies owe to its health service for anticompetitive activities involving Avastin and Lucentis.